Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern
The targeted delivery of theranostic agents to the cancer cells is one of the major challenges
and an active field of research in the development of cancer chemotherapeutic approaches …
and an active field of research in the development of cancer chemotherapeutic approaches …
[PDF][PDF] Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity Concern
S Akhter, MZ Ahmad, A Singh, I Ahmad… - Current …, 2011 - researchgate.net
The targeted delivery of theranostic agents to the cancer cells is one of the major challenges
and an active field of research in the development of cancer chemotherapeutic approaches …
and an active field of research in the development of cancer chemotherapeutic approaches …
[引用][C] Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity Concern
S AKHTER, MZ AHMAD, A SINGH… - Current …, 2011 - pascal-francis.inist.fr
Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and
Toxicity Concern CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Toxicity Concern CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[PDF][PDF] Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity Concern
S Akhter, MZ Ahmad, A Singh, I Ahmad… - Current …, 2011 - academia.edu
The targeted delivery of theranostic agents to the cancer cells is one of the major challenges
and an active field of research in the development of cancer chemotherapeutic approaches …
and an active field of research in the development of cancer chemotherapeutic approaches …
Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern
S Akhter, Z Ahmad, A Singh, I Ahmad… - Current …, 2011 - pubmed.ncbi.nlm.nih.gov
The targeted delivery of theranostic agents to the cancer cells is one of the major challenges
and an active field of research in the development of cancer chemotherapeutic approaches …
and an active field of research in the development of cancer chemotherapeutic approaches …
Cancer targeted metallic nanoparticle: Targeting overview, recent advancement and toxicity concern
S Akhter, MZ Ahmad, M Rahman, GK Jain… - Current …, 2011 - ksascholar.dri.sa
The targeted delivery of theranostic agents to the cancer cells is one of the major challenges
and an active field of research in the development of cancer chemotherapeutic approaches …
and an active field of research in the development of cancer chemotherapeutic approaches …
Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern.
S Akhter, Z Ahmad, A Singh, I Ahmad… - Current …, 2011 - europepmc.org
The targeted delivery of theranostic agents to the cancer cells is one of the major challenges
and an active field of research in the development of cancer chemotherapeutic approaches …
and an active field of research in the development of cancer chemotherapeutic approaches …
[PDF][PDF] Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity Concern
S Akhter, MZ Ahmad, A Singh, I Ahmad… - Current …, 2011 - academia.edu
The targeted delivery of theranostic agents to the cancer cells is one of the major challenges
and an active field of research in the development of cancer chemotherapeutic approaches …
and an active field of research in the development of cancer chemotherapeutic approaches …
[PDF][PDF] Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity Concern
S Akhter, MZ Ahmad, A Singh, I Ahmad… - Current …, 2011 - researchgate.net
The targeted delivery of theranostic agents to the cancer cells is one of the major challenges
and an active field of research in the development of cancer chemotherapeutic approaches …
and an active field of research in the development of cancer chemotherapeutic approaches …